$INO INOVIO and IVI Partner with Seoul National University Hospital to Start Phase 1/2 Clinical Trial of INOVIO's COVID-19 DNA Vaccine (INO-4800) in South Korea 

$MRNA $SRNE $CODX $IBIO $NVAX $MRK $JNJ $NVAX $GILD #covid19 #coronavirus #vaccine #nasdaq

https://t.co/rWkFx66pEb